{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:18:38Z","timestamp":1772104718098,"version":"3.50.1"},"reference-count":70,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2010.0010","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:19:15Z","timestamp":1525252755000},"source":"Crossref","is-referenced-by-count":5,"title":["Drug Resistant Tuberculosis"],"prefix":"10.3238","author":[{"given":"Robert","family":"Loddenkemper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Hauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2010,1,7]]},"reference":[{"key":"10.3238\/arztebl.2010.0010_ref1","unstructured":"World Health Organization: Report No. 4, 2008."},{"key":"10.3238\/arztebl.2010.0010_ref2","unstructured":"World Health Organization: Emergency update 2008."},{"key":"10.3238\/arztebl.2010.0010_ref3","unstructured":"Robert Koch-Institut: Robert Koch-Institut 2009, Berlin"},{"key":"10.3238\/arztebl.2010.0010_ref4","unstructured":"World Health Organization: WHO, Geneva, Switzerland"},{"key":"10.3238\/arztebl.2010.0010_ref5","doi-asserted-by":"crossref","unstructured":"Eker B, Orzmann J, Migliori GB, et al.: Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis 2008; 14: 1700\u20136.","DOI":"10.3201\/eid1411.080729"},{"key":"10.3238\/arztebl.2010.0010_ref6","doi-asserted-by":"crossref","unstructured":"Cohen T, Colijn C, Wright A, Zignol M, Pym A, Murray M: Challenges in estimating the total burden of drug-resistant tuberculosis. Am J Respir Crit Care Med 2008; 177: 1302\u20136.","DOI":"10.1164\/rccm.200801-175PP"},{"key":"10.3238\/arztebl.2010.0010_ref7","doi-asserted-by":"crossref","unstructured":"Loddenkemper R, Sagebiel D, Brendel A: Strategies against multidrug-resistant tuberculosis. Eur Respir J 2002; 20(Suppl 36): 66\u201377.","DOI":"10.1183\/09031936.02.00401302"},{"key":"10.3238\/arztebl.2010.0010_ref8","doi-asserted-by":"crossref","unstructured":"French CE, Glynn JR, Kruijshaar ME, Ditah IC, Delpech V, Abubakar I: The association between HIV and antituberculosis drug resistance. Eur Respir J 2008; 32: 718\u201325.","DOI":"10.1183\/09031936.00022308"},{"key":"10.3238\/arztebl.2010.0010_ref9","unstructured":"WHO Regional Office for Europe: ,WHO Kopenhagen, D\u00e4nemark 2007."},{"key":"10.3238\/arztebl.2010.0010_ref10","doi-asserted-by":"crossref","unstructured":"Nunn P, Reid A, De Cock KM: Tuberculosis and HIV infection: the global setting. J Infect Dis 2007;196: 5\u201314.","DOI":"10.1086\/518660"},{"key":"10.3238\/arztebl.2010.0010_ref11","doi-asserted-by":"crossref","unstructured":"Gandhi NR, Moll A, Sturm AW, Pawinski R, et al.: Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368: 1575\u201380.","DOI":"10.1016\/S0140-6736(06)69573-1"},{"key":"10.3238\/arztebl.2010.0010_ref12","doi-asserted-by":"crossref","unstructured":"R\u00fcsch-Gerdes S, Hillemann D: Moderne mykobakteriologische Labordiagnostik. Pneumologie 2008; 62: 533\u201340.","DOI":"10.1055\/s-2008-1038242"},{"key":"10.3238\/arztebl.2010.0010_ref13","unstructured":"Deutsches Zentralkomitee zur Bek\u00e4mpfung der Tuberkulose: Richtlinien zur medikament\u00f6sen Behandlung der Tuberkulose im Erwachsenen- und Kindesalter. Pneumologie 2001; 33: 494\u2013511."},{"key":"10.3238\/arztebl.2010.0010_ref14","unstructured":"Caminero JA: Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006; 10: 829\u201337."},{"key":"10.3238\/arztebl.2010.0010_ref15","doi-asserted-by":"crossref","unstructured":"Blaas SH, M\u00fctterlein R, Weig J, et al.: Extensively drug resistant tuberculosis in a high income country: A report of four unrelated cases. BMC Infect Dis 2008; 8: 60.","DOI":"10.1186\/1471-2334-8-60"},{"key":"10.3238\/arztebl.2010.0010_ref16","doi-asserted-by":"crossref","unstructured":"Kwon YS, Kim YH, Suh GY, et al.: Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. CID 2008; 47: 496\u2013502.","DOI":"10.1086\/590005"},{"key":"10.3238\/arztebl.2010.0010_ref17","doi-asserted-by":"crossref","unstructured":"Mitnick CD, Shin SS, Seung KJ, et al.: Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008; 359: 563\u201374.","DOI":"10.1056\/NEJMoa0800106"},{"key":"10.3238\/arztebl.2010.0010_ref18","doi-asserted-by":"crossref","unstructured":"Kim DH, Kim HJ, Park S-K, et al.: Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med 2008; 178: 1075\u201382.","DOI":"10.1164\/rccm.200801-132OC"},{"key":"10.3238\/arztebl.2010.0010_ref19","unstructured":"World Health Organization: Building on and enhancing DOTS to meet the TB-related Millenium Development Goals. World Health Organization, Geneva 2006."},{"key":"10.3238\/arztebl.2010.0010_ref20","doi-asserted-by":"crossref","unstructured":"Floyd K, Pantoja A: Financial resources required for tuberculosis control to achieve global targets set for 2015. Bull World Health Organ 2008; 86: 568\u201376.","DOI":"10.2471\/BLT.07.049767"},{"key":"10.3238\/arztebl.2010.0010_ref21","doi-asserted-by":"crossref","unstructured":"Migliori GB, Loddenkemper R, Blasi F, Raviglione MC: 125 years after Robert Koch\u00b4s discovery of the tubercle bacillus: Is \u201cscience\u201d enough to tackle the epidemic? Eur Respir J 2007; 29: 423\u20137.","DOI":"10.1183\/09031936.00001307"},{"key":"10.3238\/arztebl.2010.0010_ref22","doi-asserted-by":"crossref","unstructured":"Raviglione MC, Uplekar MW: WHO\u00b4s new Stop TB Strategy. Lancet 2006; 367: 952\u20135.","DOI":"10.1016\/S0140-6736(06)68392-X"},{"key":"10.3238\/arztebl.2010.0010_ref23","unstructured":"World Health Organization: Guidelines for establishing DOTS-Plus projects for the management of multidrug-resistant tuberculosis (MDR-TB). World Health Organization, WHO\/CDS\/TB\/2000.278. Geneva, Schweiz 2000."},{"key":"10.3238\/arztebl.2010.0010_ref24","doi-asserted-by":"crossref","unstructured":"Spigelman MK: New tuberculosis therapeutics: A growing pipeline. JID 2007; 196: S28\u201334.","DOI":"10.1086\/518663"},{"key":"10.3238\/arztebl.2010.0010_ref25","doi-asserted-by":"crossref","unstructured":"Baumann S, Eddine AN, Kaufmann SHE: Progress in tuberculosis vaccine development. Curr Opin Immunol 2006; 18: 438\u201348.","DOI":"10.1016\/j.coi.2006.05.016"},{"key":"10.3238\/arztebl.2010.0010_ref26","doi-asserted-by":"crossref","unstructured":"Migliori GB, Besozzi G, Girardi E, et al.: Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J 2007; 30: 623\u20136.","DOI":"10.1183\/09031936.00077307"},{"key":"10.3238\/arztebl.2010.0010_ref27","unstructured":"Scholten JN, de Vlas SJ, Zaleskis R: Under-reporting of HIV infection among cohorts of TB patients in the WHO European Region, 2003\u20132004. Int J Tuberc Lung Dis 2008; 12: 85\u201391."},{"key":"10.3238\/arztebl.2010.0010_ref28","doi-asserted-by":"crossref","unstructured":"Kunitz F, Brodhun B, Hauer B, Haas W, Loddenkemper R: Die aktuelle Tuberkulosesituation in Deutschland und die Auswirkungen der globalen Situation. Pneumologie 2007; 61: 467\u201377.","DOI":"10.1055\/s-2007-959245"},{"key":"10.3238\/arztebl.2010.0010_ref29","unstructured":"Euro TB and the national coordinators for tuberculosis surveill-ance in the WHO European Region: Surveillance of tuberculosis in Europe. Report on tuberculosis cases notified in 2006, Institut de veille sanitaire, Saint-Maurice, France. M\u00e4rz 2008."},{"key":"10.3238\/arztebl.2010.0010_ref30","unstructured":"Chiang C-Y, Yew WW: Multidrug-resistant and extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis 2009; 13; 304\u201311."},{"key":"10.3238\/arztebl.2010.0010_ref31","doi-asserted-by":"crossref","unstructured":"Lange C, Grobusch MP, Wagner D: Extensiv-resistente Tuberkulose (XDR-TB). Dtsch Med Wochenschr 2008; 133: 374\u20136.","DOI":"10.1055\/s-2008-1046724"},{"key":"10.3238\/arztebl.2010.0010_ref32","doi-asserted-by":"crossref","unstructured":"Amor YB, Nemser B, Singh A, Sankin A, Schluger N: Underreported threat of multidrug-resistant tuberculosis in Africa. Emerg Infect Dis 2008; 14: 1345\u201352.","DOI":"10.3201\/eid1409.061524"},{"key":"10.3238\/arztebl.2010.0010_ref33","unstructured":"World Health Organization: , Geneva, WHO 2007."},{"key":"10.3238\/arztebl.2010.0010_ref34","doi-asserted-by":"crossref","unstructured":"Migliori GB, De Iaco G, Besozzi G, Centis R, Cirillo DM: First tuberculosis cases in Italy resistant to all tested drugs. Euro Surveill 2007; 12: E070517.1","DOI":"10.2807\/esw.12.20.03194-en"},{"key":"10.3238\/arztebl.2010.0010_ref35","doi-asserted-by":"crossref","unstructured":"Canetti G: The eradication of tuberculosis: theoretical problems and practical solutions. Tubercle 1962; 43: 301\u201321.","DOI":"10.1016\/S0041-3879(62)80071-3"},{"key":"10.3238\/arztebl.2010.0010_ref36","doi-asserted-by":"crossref","unstructured":"Mitchison DA: Chemotherapy of tuberculosis: a bacteriologist\u00b4s viewpoint. BMJ 1965; 1: 1333\u201340.","DOI":"10.1136\/bmj.1.5446.1333"},{"key":"10.3238\/arztebl.2010.0010_ref37","doi-asserted-by":"crossref","unstructured":"Vareldzis BP, Grosset J, de Kantor I, et al.: Drug-resistant tuberculosis, laboratory issues. WHO recommendations. Tuberc Lung Dis 1994; 75: 1\u20137.","DOI":"10.1016\/0962-8479(94)90096-5"},{"key":"10.3238\/arztebl.2010.0010_ref38","unstructured":"Fox W, Ellard GA, Mitchison DA: Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946\u20131986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999; 3: 231\u201379."},{"key":"10.3238\/arztebl.2010.0010_ref39","doi-asserted-by":"crossref","unstructured":"Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW: The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521\u20136.","DOI":"10.1056\/NEJM199302253280801"},{"key":"10.3238\/arztebl.2010.0010_ref40","unstructured":"Aerts A, Hauer B, Wanlin M, et al.: Tuberculosis and tuberculosis control in European prisons. Int J Tuberc Lung Dis 2006; 11: 1213\u201323."},{"key":"10.3238\/arztebl.2010.0010_ref41","doi-asserted-by":"crossref","unstructured":"Faustini A, Hall AJ, Perucci CA: Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158\u201363.","DOI":"10.1136\/thx.2005.045963"},{"key":"10.3238\/arztebl.2010.0010_ref42","unstructured":"Bone A, Aerts A, Grzemska M, et al.: 2001."},{"key":"10.3238\/arztebl.2010.0010_ref43","doi-asserted-by":"crossref","unstructured":"Glynn JR, Kremer K, Borgdorff MW, Rodriguez MP, van Soolingen D: Beijing\/W genotype Mycobacterium tuberculosis and drug resistance. European concerted action on new generation genetic markers and techniques for the epidemiology and control of tuberculosis. Emerg Infect Dis 2006; 12: 736\u201343.","DOI":"10.3201\/eid1205.050400"},{"key":"10.3238\/arztebl.2010.0010_ref44","doi-asserted-by":"crossref","unstructured":"Davies PDO: The world wide increase in tuberculosis: how demographic change, HIV infection and increasing numbers in poverty are increasing tuberculosis. Ann Med 2003; 35: 235\u201343.","DOI":"10.1080\/07853890310005713"},{"key":"10.3238\/arztebl.2010.0010_ref45","doi-asserted-by":"crossref","unstructured":"Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione R, Dye C: The growing burden of tuberculosis. Global trends and interactions with the HIV epidemic. Arch Intern Med 2003; 163: 1009\u201321.","DOI":"10.1001\/archinte.163.9.1009"},{"key":"10.3238\/arztebl.2010.0010_ref46","doi-asserted-by":"crossref","unstructured":"Schwalbe N , Harrington P: HIV and tuberculosis in the former Soviet Union. Lancet 2002; 360: 19\u201320.","DOI":"10.1016\/S0140-6736(02)11805-8"},{"key":"10.3238\/arztebl.2010.0010_ref47","unstructured":"Hauer B, Kunitz F, Sagebiel D, Niemann S, Diel R, Loddenkemper R: \u00dcbersicht zur DZK-Studie: \u201eUntersuchungen zur Tuberkulose in Deutschland: Molekulare Epidemiologie, Resistenzsituation und Behandlung\u201c. In: Deutsches Zentralkomitee zur Bek\u00e4mpfung der Tuberkulose. 30. Informationsbericht, Berlin 2007, 74\u201384."},{"key":"10.3238\/arztebl.2010.0010_ref48","doi-asserted-by":"crossref","unstructured":"Pai M, O\u2019Brien R: New diagnostics for latent and active tuberculosis: state of the art and future prospects. Semin Respir Crit Care Med 2008; 29: 560\u20138.","DOI":"10.1055\/s-0028-1085707"},{"key":"10.3238\/arztebl.2010.0010_ref49","unstructured":"World Health Organization and the UNICEF\/UNDP\/World Bank\/WHO special programme for research and training in tropical diseases (TDR)."},{"key":"10.3238\/arztebl.2010.0010_ref50","doi-asserted-by":"crossref","unstructured":"Parrish N, Carrol K: Importance of improved TB diagnostics in addressing the extensively drug-resistant TB crisis. Future Microbiol 2008; 3: 405\u201313.","DOI":"10.2217\/17460913.3.4.405"},{"key":"10.3238\/arztebl.2010.0010_ref51","doi-asserted-by":"crossref","unstructured":"Raviglione MC, Smith IM: XDR tuberculosis\u2014implications for global public health. N Engl J Med 2007; 356: 656\u20139.","DOI":"10.1056\/NEJMp068273"},{"key":"10.3238\/arztebl.2010.0010_ref52","unstructured":"World Health Organization: 3rd ed. Genf, Schweiz 2003."},{"key":"10.3238\/arztebl.2010.0010_ref53","doi-asserted-by":"crossref","unstructured":"Mak A, Thomas A, del Granado M, Zaleskis R, Mouzafavora N, Menzies D: Influence of multidrug resistance on tuberculosis treatment outcomes with standardized regimens. Am J Respir Crit Care Med 2008; 178: 306\u201312.","DOI":"10.1164\/rccm.200802-240OC"},{"key":"10.3238\/arztebl.2010.0010_ref54","doi-asserted-by":"crossref","unstructured":"Franke MF, Appleton SC, Bayona J: Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment. Clin Infect Dis 2008; 46: 1844\u201351.","DOI":"10.1086\/588292"},{"key":"10.3238\/arztebl.2010.0010_ref55","doi-asserted-by":"crossref","unstructured":"Banerjee R, Allen J, Westenhouse J, et al.: Extensively drug-resistant tuberculosis in California, 1993\u20132006. CID 2008; 47: 450\u20137.","DOI":"10.1086\/590009"},{"key":"10.3238\/arztebl.2010.0010_ref56","doi-asserted-by":"crossref","unstructured":"Shah NS, Pratt R, Armstrong L, Robison V, Castro KG, Cegielski JP: Extensively drug-resistant tuberculosis in the United States, 1993\u20132007. JAMA 2008; 300: 2153\u201360.","DOI":"10.1001\/jama.300.18.2153"},{"key":"10.3238\/arztebl.2010.0010_ref57","doi-asserted-by":"crossref","unstructured":"Chiang C-Y, Enarson DA, Yu MC, et al.: Outcome of pulmonary multidrug-resistant tuberculosis : a 6-yr follow-up study. Eur Respir J 2006; 28: 980\u20135.","DOI":"10.1183\/09031936.06.00125705"},{"key":"10.3238\/arztebl.2010.0010_ref58","doi-asserted-by":"crossref","unstructured":"Leimane V, Riekstina V, Holtz TH, et al.: Clinical outcome of individ- ualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet 2005; 365: 318\u201326.","DOI":"10.1016\/S0140-6736(05)17786-1"},{"key":"10.3238\/arztebl.2010.0010_ref59","unstructured":"Laserson KF, Thorpe LE, Leimane V, et al.: Speaking the same language : treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005; 9: 640\u20135."},{"key":"10.3238\/arztebl.2010.0010_ref60","doi-asserted-by":"crossref","unstructured":"Keshavjee S, Gelmanova I, Farmer PE, et al.: Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008; 372: 1403\u20139. Epub 2008 Aug 22","DOI":"10.1016\/S0140-6736(08)61204-0"},{"key":"10.3238\/arztebl.2010.0010_ref61","doi-asserted-by":"crossref","unstructured":"Brown RE, Miller B, Taylor WR, et al.: Health-care expenditures for tuberculosis in the United States. Arch Intern Med 1995; 155: 1595\u20131600.","DOI":"10.1001\/archinte.155.15.1595"},{"key":"10.3238\/arztebl.2010.0010_ref62","unstructured":"Rajbhandary SS, Marks SM, Bock NN: Costs of patients hospitalized for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2004; 8: 1012\u20136."},{"key":"10.3238\/arztebl.2010.0010_ref63","unstructured":"European Center for Disease Prevention and Control (ECDC). Framework action plan to fight tuberculosis in the European Union. Stockholm, February 2008."},{"key":"10.3238\/arztebl.2010.0010_ref64","unstructured":"World Health Organization: Plan to stop TB in 18 high priority countries in the WHO European Region, 2007\u20132015. WHO, Geneva 2007."},{"key":"10.3238\/arztebl.2010.0010_ref65","doi-asserted-by":"crossref","unstructured":"Gupta R, Cegielski JP, Espinal MA, et al.: Increasing transparency in partnerships for health\u2014introducing the Green Light Committee. Trop Med Int Health 2002; 7: 970\u201376.","DOI":"10.1046\/j.1365-3156.2002.00960.x"},{"key":"10.3238\/arztebl.2010.0010_ref66","unstructured":"Caminero JA: Likelihood of generating MDR-TB and XDR-TB under adequate National Tuberculosis Control Programme implementation. Int J Tuberc Lung Dis 2008; 12: 869\u201377."},{"key":"10.3238\/arztebl.2010.0010_ref67","doi-asserted-by":"crossref","unstructured":"Cobelens FGJ, Heldal E, Kimerling ME, et al.: Scaling up programmatic management of drug-resistant tuberculosis: a prioritised research agenda. Plos Medicine 2008; 5: 1037\u201342.","DOI":"10.1371\/journal.pmed.0050150"},{"key":"10.3238\/arztebl.2010.0010_ref68","unstructured":""},{"key":"10.3238\/arztebl.2010.0010_ref69","unstructured":""},{"key":"10.3238\/arztebl.2010.0010_ref70","unstructured":""}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T14:12:38Z","timestamp":1638799958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2010.0010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,7]]},"references-count":70,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2010.0010","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,7]]}}}